Related Experiment Videos
Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol
1Research Service, Veterans Administration Medical Center, Syracuse, NY.
Neuropsychobiology
|January 1, 1990
Summary
Chronic haloperidol treatment in rats reveals complex neuroadaptations, not simple autoreceptor changes, impacting behavioral suppression and responses to apomorphine.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Chronic neuroleptic administration clinically mimics a delayed onset of action.
- Understanding the neurochemical underpinnings of this delay is crucial for optimizing treatment.
Purpose of the Study:
- To investigate neurochemical mechanisms behind the delayed onset of behavioral suppression induced by chronic haloperidol.
- To examine dopamine autoreceptor sensitivity and postsynaptic adaptations following subthreshold haloperidol treatment.
Main Methods:
- Rats received chronic haloperidol (0.1 mg/kg) for 21 days.
- Apomorphine (low dose) was administered post-withdrawal to assess neurochemical responses.
- Behavioral suppression and yawning were measured as indicators of dopaminergic activity.
Main Results:
- Haloperidol treatment did not induce dopamine autoreceptor supersensitivity or postsynaptic supersensitivity.
- Rats treated with haloperidol showed reduced sensitivity to apomorphine-induced yawning.
- Metabolic changes were comparable between haloperidol and vehicle groups, indicating subthreshold effects.
Conclusions:
- Therapeutic doses of neuroleptics induce complex pre- and postsynaptic neuroadaptive changes.
- These adaptations involve both up- and down-regulation of dopaminergic systems.
- The mechanisms underlying the delayed onset of neuroleptic action are multifaceted.